Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives
- PMID: 15757962
- DOI: 10.1093/rheumatology/keh595
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives
Abstract
Objective: There is no "gold standard" to assess disease activity in patients with ankylosing spondylitis (AS). It is known that patients and physicians have different opinions about disease activity. The objective was therefore to investigate on which criteria patients with AS and physicians base their judgement on disease activity.
Methods: A cohort of 203 AS out-patients fulfilling the modified New York criteria included in the ongoing long-term follow-up was analysed. The Assessment in Ankylosing Spondylitis (ASAS) International Working Group has established different domains relevant for outcome in AS. Each domain includes a number of instruments for making assessments, and all these instruments are included in the Outcome in Ankylosing Spondylitis International Study and were made every 6 months for 2 yr. Disease activity from the patient perspective as well as from the physician perspective was analysed using the patient's or the physician's global assessment of disease activity [visual analogue scale (VAS): 0 (best)-10 (worst)] by dichotomizing into "high disease activity" (VAS > or = 6.0) and "low disease activity" (VAS < or = 4.0). Data reduction by principal components analysis (PCA) was performed to distinguish factors capturing correlated instruments. Discriminant analysis with the factor loadings was performed to discriminate between a low and a high disease activity state from both the patient's and the physician's perspective. Multiple regression analysis on the discriminant scores was performed to prioritize the instruments.
Results: PCA revealed four factors: spinal mobility, physician assessments, patient assessments and laboratory assessments (Cronbach's alpha 0.52-0.80; explained variance 61%). Discriminant function analysis showed that the factor "patient assessments" was most important (pooled correlation 0.85) in discriminating between a low and a high disease activity state as defined by the patient. The other three factors contributed marginally (pooled correlation <0.30). In contrast, the factors "physician's assessments" (pooled correlation 0.62), "spinal mobility" (pooled correlation 0.52) and "laboratory assessments" (pooled correlation 0.48) contributed most to the physician's perspective. The factor "patient assessments" did not contribute at all (pooled correlation 0.05). Multivariate analysis on the discriminant scores showed that the instruments "pain spine", "BASFI", "pain joints" and "BASDAI fatigue" explained more than 90% of variance in the case of the patient perspective. The instruments "cervical rotation", "swollen joint count", "CRP" and "intermalleolar distance" explained more than 90% of variance in case of physician perspective.
Conclusion: AS patients rate disease activity on the basis of complaints while physicians rate disease activity on the basis of instruments related to disease severity and inflammation.
Similar articles
-
[Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].Z Rheumatol. 2003 Jun;62(3):264-73. doi: 10.1007/s00393-003-0522-y. Z Rheumatol. 2003. PMID: 12827403 Clinical Trial. German.
-
Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.Arthritis Rheum. 2006 Dec 15;55(6):960-3. doi: 10.1002/art.22342. Arthritis Rheum. 2006. PMID: 17139643 Clinical Trial.
-
Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.J Rheumatol. 1999 Apr;26(4):975-9. J Rheumatol. 1999. PMID: 10229431 Clinical Trial.
-
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.J Rheumatol. 1999 Apr;26(4):951-4. J Rheumatol. 1999. PMID: 10229426 Review.
-
Patient-assessed health in ankylosing spondylitis: a structured review.Rheumatology (Oxford). 2005 May;44(5):577-86. doi: 10.1093/rheumatology/keh549. Epub 2005 Feb 3. Rheumatology (Oxford). 2005. PMID: 15695297 Review.
Cited by
-
Disease activity in longstanding ankylosing spondylitis: a correlation of clinical and magnetic resonance imaging findings.Clin Rheumatol. 2008 Apr;27(4):449-55. doi: 10.1007/s10067-007-0726-7. Epub 2007 Oct 2. Clin Rheumatol. 2008. PMID: 17912578
-
Cardiac Manifestations of Seronegative Spondyloarthropathy in a Human Leukocyte Antigen B27-Positive African American Woman: A Case Report With Literature Review.CASE (Phila). 2019 Jun 12;3(5):239-243. doi: 10.1016/j.case.2019.05.001. eCollection 2019 Oct. CASE (Phila). 2019. PMID: 31709378 Free PMC article.
-
An Assessment of Thyroid Dysfunction and Related Parameters in Patients With Systemic Autoimmune Disorders.Cureus. 2023 Aug 1;15(8):e42783. doi: 10.7759/cureus.42783. eCollection 2023 Aug. Cureus. 2023. PMID: 37664252 Free PMC article.
-
Prevalence, influencing factors, and prediction model construction of anemia in ankylosing spondylitis based on real-world data: An exploratory study.PLoS One. 2025 Feb 5;20(2):e0318332. doi: 10.1371/journal.pone.0318332. eCollection 2025. PLoS One. 2025. PMID: 39908327 Free PMC article.
-
Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis.Arthritis Care Res (Hoboken). 2022 Feb;74(2):268-273. doi: 10.1002/acr.24465. Epub 2022 Jan 13. Arthritis Care Res (Hoboken). 2022. PMID: 32986932 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous